1. Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review

Carol Gravinese; Matteo Bianco; Enrico Cerrato; Paola Destefanis; Alessia Luciano; Alessandro Bernardi; Simone Bellucca; Ferdinando Varbella; Fiorenzo Gaita; Roberto Pozzi

Volume 2, Issue 4 , Autumn 2017, , Pages 94-101

http://dx.doi.org/10.15171/hpr.2017.24

Abstract
  Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone of antiplatelet therapy and is used in secondary prevention of cardiovascular disease. Disagreement over the optimal maintenance dosage still exists; in America and Europe the most used doses of aspirin ...  Read More